Transaction · 0001225208-26-005132

Markowitz Wayne

Markowitz Wayne, CVP, JAPAC, reported a transaction classified as grant at Edwards Lifesciences Corp involving 26400.000000 shares for an estimated $0.00. Reported holdings after the transaction were 26400.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

grantSEC transaction code ACVP, JAPAC
EWEdwards Lifesciences Corp
Trade date
May 07, 2026
Filing date
May 12, 2026
View on SEC Insider profile
Disclosed value$0Shares × reported price
Shares traded26.4k$0.00 per share
Holdings after26.4kDirect
% of reported position tradedUnavailableThis security and ownership context
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

EW price since this filing

Daily closing prices, with the filing date and available return windows
EW · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago1w ago1d ago
Returns since7d30d90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Derivative
Type
grant
Code A
Identifier
0001225208-26-005132
Employee Stock Option (Right to Acquire)
Transaction date
May 07, 2026
Filed May 12, 2026, 01:33 AM · 5d delay
Shares
26,400 sh
$0.00 per share
Estimated value
$0
Computed from shares × price
Holdings after
26,400 sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Derivative Transaction Direct Ownership Large Holdings Increase
Filing-only score

-10 points

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

How this score is calculated
  • direct_ownership+6 points

    direct_or_indirect_ownership = D

    Direct ownership reports the insider's personal stake.
  • derivative_transaction-16 points

    is_derivative = true

    Derivative exercise rows are less discretionary than open-market purchases.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

CVP, JAPAC

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    These restricted stock units were granted on May 7, 2026 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable co…

  2. F2

    These options were granted on May 7, 2026 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one ye…

  3. F3

    Reflects the target number of shares (the Target Award) covered by restricted stock units granted on May 7, 2026 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Progr…

Original filing · 0001225208-26-005132
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

EW